These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 20549835)

  • 1. Effect of absorption site on the pharmacokinetics of sublingual asenapine in healthy male subjects.
    Gerrits M; de Greef R; Peeters P
    Biopharm Drug Dispos; 2010 Jul; 31(5-6):351-7. PubMed ID: 20549835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valproate reduces the glucuronidation of asenapine without affecting asenapine plasma concentrations.
    Gerrits MG; de Greef R; Dogterom P; Peeters PA
    J Clin Pharmacol; 2012 May; 52(5):757-65. PubMed ID: 21628604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asenapine for schizophrenia and bipolar disorder: a review of the efficacy and safety profile for this newly approved sublingually absorbed second-generation antipsychotic.
    Citrome L
    Int J Clin Pract; 2009 Dec; 63(12):1762-84. PubMed ID: 19840150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioequivalence following buccal and sublingual placement of fentanyl buccal tablet 400 microg in healthy subjects.
    Darwish M; Kirby M; Jiang JG; Tracewell W; Robertson P
    Clin Drug Investig; 2008; 28(1):1-7. PubMed ID: 18081355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of food on the high clearance drug asenapine after sublingual administration to healthy male volunteers.
    Dogterom P; de Greef R; Peeters PA
    Eur J Clin Pharmacol; 2015 Jan; 71(1):65-74. PubMed ID: 25552402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asenapine for the treatment of manic and mixed episodes associated with bipolar I disorder: from clinical research to clinical practice.
    Fagiolini A; Forgione RN; Morana B; Maccari M; Goracci A; Bossini L; Pellegrini F; Cuomo A; Casamassima F
    Expert Opin Pharmacother; 2013 Mar; 14(4):489-504. PubMed ID: 23356509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asenapine pharmacokinetics in hepatic and renal impairment.
    Peeters P; Bockbrader H; Spaans E; Dogterom P; Lasseter K; Marbury T; Gibson GL; de Greef R
    Clin Pharmacokinet; 2011 Jul; 50(7):471-81. PubMed ID: 21651314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asenapine: a new antipsychotic option.
    Henry JM; Fuller MA
    J Pharm Pract; 2011 Oct; 24(5):447-51. PubMed ID: 22156709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asenapine pharmacokinetics and tolerability in a pediatric population.
    Dogterom P; Riesenberg R; de Greef R; Dennie J; Johnson M; Pilla Reddy V; Miltenburg AM; Findling RL; Jakate A; Carrothers TJ; Troyer MD
    Drug Des Devel Ther; 2018; 12():2677-2693. PubMed ID: 30214156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asenapine Treatment in Pediatric Patients with Bipolar I Disorder or Schizophrenia: A Review.
    Stepanova E; Grant B; Findling RL
    Paediatr Drugs; 2018 Apr; 20(2):121-134. PubMed ID: 29170943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asenapine: a less effective, yet, more dangerous neuroleptic!
    Prescrire Int; 2012 Oct; 21(131):229-32. PubMed ID: 23185842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asenapine for the Acute Treatment of Pediatric Manic or Mixed Episode of Bipolar I Disorder.
    Findling RL; Landbloom RL; Szegedi A; Koppenhaver J; Braat S; Zhu Q; Mackle M; Chang K; Mathews M
    J Am Acad Child Adolesc Psychiatry; 2015 Dec; 54(12):1032-41. PubMed ID: 26598478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology and efficacy of asenapine for manic and mixed states in adults with bipolar disorder.
    McIntyre RS
    Expert Rev Neurother; 2010 May; 10(5):645-9. PubMed ID: 20420486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asenapine-Induced Acute Dystonia in an Adolescent Male.
    Bhuyan D; Ghosh S; Bhattacharya A; Praharaj SK
    J Child Adolesc Psychopharmacol; 2016 Dec; 26(10):955-956. PubMed ID: 27154343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asenapine in the treatment of acute mania in bipolar I disorder: a randomized, double-blind, placebo-controlled trial.
    McIntyre RS; Cohen M; Zhao J; Alphs L; Macek TA; Panagides J
    J Affect Disord; 2010 Apr; 122(1-2):27-38. PubMed ID: 20096936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic Profile of the Asenapine Transdermal System (HP-3070).
    Suzuki K; Castelli M; Komaroff M; Starling B; Terahara T; Citrome L
    J Clin Psychopharmacol; 2021 May-Jun 01; 41(3):286-294. PubMed ID: 33734167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, Double-Blind, Placebo-Controlled Trial of Asenapine Maintenance Therapy in Adults With an Acute Manic or Mixed Episode Associated With Bipolar I Disorder.
    Szegedi A; Durgam S; Mackle M; Yu SY; Wu X; Mathews M; Landbloom RP
    Am J Psychiatry; 2018 Jan; 175(1):71-79. PubMed ID: 28946761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term safety and pharmacokinetic profile of asenapine in older patients with psychosis.
    Dubovsky SL; Frobose C; Phiri P; de Greef R; Panagides J
    Int J Geriatr Psychiatry; 2012 May; 27(5):472-82. PubMed ID: 21755540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A crossover pharmacokinetic study of misoprostol by the oral, sublingual and buccal routes.
    Frye LJ; Byrne ME; Winikoff B
    Eur J Contracept Reprod Health Care; 2016 Aug; 21(4):265-8. PubMed ID: 27102981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asenapine: Pharmacological Aspects and Role in Psychiatric Disorders.
    Reyad AA; Mishriky R
    Psychiatr Danub; 2019 Jun; 31(2):157-161. PubMed ID: 31291219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.